Concert Genetics
Phil Hertik is the former founder, chairman and CEO of Windsor Health Group, a holding company for healthcare acquisitions, which he launched in 2000 and sold in 2010. Windsor developed Windsor Medicare Extra, a leading regional Medicare Advantage plan.
In the mid-1990s Hertik served as an independent consultant and investor in healthcare and also led Coventry Corporation, a publicly traded regional managed care and insurance organization. He’s additionally been at the helm of Dental Health Management, Inc. and held senior executive positions with Preferred Care, HealthAmerica, Saratoga Hospital and Ernst & Ernst, where he had a practice concentration in healthcare. Mr. Hertik holds bachelors and masters degrees from the State University of New York and is a Certified Public Accountant. He holds directorships at other companies, including Amplion Clinical Communications and Unity Physician Partners. He previously sat on the boards of Tandem Health Care, Inc., Esoterix, Inc., CompBenefits Corporation, Athena Diagnostics, Inc. and Coventry Corporation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.